MICROSATELLITE-STABLE COLORECTAL CANCER
Clinical trials for MICROSATELLITE-STABLE COLORECTAL CANCER explained in plain language.
Never miss a new study
Get alerted when new MICROSATELLITE-STABLE COLORECTAL CANCER trials appear
Sign up with your email to follow new studies for MICROSATELLITE-STABLE COLORECTAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail aims to tackle Hard-to-Treat colorectal cancer
Disease control TerminatedThis study tested whether a combination of four drugs (BMS-986340, nivolumab, trifluridine/tipiracil, and bevacizumab) could help control advanced colorectal cancer that has stopped responding to standard treatments. It included 7 adults with a specific type of cancer called micr…
Matched conditions: MICROSATELLITE-STABLE COLORECTAL CANCER
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 00:32 UTC
-
New combo therapy aims to control hard-to-treat colorectal and pancreatic cancers
Disease control OngoingThis study tests whether combining two immunotherapy drugs (nivolumab and ipilimumab) with radiation therapy can help control colorectal and pancreatic cancers that are either microsatellite stable (MSS) or MSI-high. About 84 adults with these cancers will receive the treatment. …
Matched conditions: MICROSATELLITE-STABLE COLORECTAL CANCER
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
New drug combo targets tough cancers in early trial
Disease control OngoingThis early-phase study tests a new drug (DKY709) alone or with another drug (PDR001) in people with advanced solid tumors like lung cancer, melanoma, and others that have stopped responding to standard treatments. The main goal is to check safety and find the right dose. About 98…
Matched conditions: MICROSATELLITE-STABLE COLORECTAL CANCER
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 14, 2026 12:04 UTC